These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36749083)

  • 1. Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy.
    Kumar L; Verma S; Joshi K; Sharma S
    Crit Rev Ther Drug Carrier Syst; 2023; 40(3):47-94. PubMed ID: 36749083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box.
    Martins P; Jesus J; Santos S; Raposo LR; Roma-Rodrigues C; Baptista PV; Fernandes AR
    Molecules; 2015 Sep; 20(9):16852-91. PubMed ID: 26389876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Most Recent Discoveries in Heterocyclic Nanoformulations for Targeted Anticancer Therapy.
    Bhattacharya S; Patel R; Joshi A
    Mini Rev Med Chem; 2022; 22(13):1735-1751. PubMed ID: 35114919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.
    Sachdeva H; Khaturia S; Saquib M; Khatik N; Khandelwal AR; Meena R; Sharma K
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6438-6467. PubMed ID: 35900713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial (Thematic Issue Role of Heteroaromatics as Anticancer Agents).
    Kaur H
    Anticancer Agents Med Chem; 2016; 16(10):1204. PubMed ID: 27592681
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic nanocatalysts as multifunctional platforms in cancer therapy through the synthesis of anticancer drugs and facilitated Fenton reaction.
    Khan S; Sharifi M; Hasan A; Attar F; Edis Z; Bai Q; Derakhshankhah H; Falahati M
    J Adv Res; 2021 May; 30():171-184. PubMed ID: 34026294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological Targets.
    Amewu RK; Sakyi PO; Osei-Safo D; Addae-Mensah I
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
    Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally Occurring O-Heterocycles as Anticancer Agents.
    Avula SK; Das B; Csuk R; Al-Harrasi A
    Anticancer Agents Med Chem; 2022; 22(19):3208-3218. PubMed ID: 34749628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
    Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M
    Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer Potential of the S-Heterocyclic Ring Containing Drugs and its Bioactivation to Reactive Metabolites.
    Maji S; Debnath B; Panda S; Manna T; Maity A; Dayaramani R; Nath R; Khan SA; Akhtar MJ
    Chem Biodivers; 2024 Jul; 21(7):e202400473. PubMed ID: 38723201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterocyclic Scaffolds: Centrality in Anticancer Drug Development.
    Ali I; Lone MN; Al-Othman ZA; Al-Warthan A; Sanagi MM
    Curr Drug Targets; 2015; 16(7):711-34. PubMed ID: 25751009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrogen-containing heterocyclic quinones: a class of potential selective antitumor agents.
    Garuti L; Roberti M; Pizzirani D
    Mini Rev Med Chem; 2007 May; 7(5):481-9. PubMed ID: 17504183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments of metal N-heterocyclic carbenes as anticancer agents.
    Aher SB; Muskawar PN; Thenmozhi K; Bhagat PR
    Eur J Med Chem; 2014 Jun; 81():408-19. PubMed ID: 24858545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets.
    Mushtaq A; Wu P; Naseer MM
    Pharmacol Ther; 2024 Feb; 254():108579. PubMed ID: 38160914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphur Containing Heterocyclic Compounds as Anticancer Agents.
    Kaur B; Singh G; Sharma V; Singh I
    Anticancer Agents Med Chem; 2023; 23(8):869-881. PubMed ID: 36545721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines.
    Tandon R; Singh I; Luxami V; Tandon N; Paul K
    Chem Rec; 2019 Feb; 19(2-3):362-393. PubMed ID: 29943894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Developments in the Pyran-Based Analogues as Anticancer Agents.
    Grover P; Bhardwaj M; Mehta L; Kapoor G; Chawla PA
    Anticancer Agents Med Chem; 2022; 22(19):3239-3268. PubMed ID: 34802409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.